October 12 at 7:45 am PDT/10:45 am EDT
Individuals across the US have adapted to a largely isolated lifestyle due to COVID-19, and many do not expect to return to normalcy until a COVID-19 vaccine is developed. Even with a vaccine, challenges and questions, such as vaccine access and public trust, will remain top of mind. While efforts in vaccine development surge forward, research on treatments for the symptoms of COVID-19 holds promise for preventing disease and extending life for patients with COVID-19. Experts at the forefront of research and development will discuss current standings and projections for COVID-19 vaccines and therapies, and will address some of the most pressing questions around the future of R&D for COVID-19.
This session will incorporate live polling, presented by the Harris Poll. This interactive feature is available for registered participants only.
Moderator
Meg Tirrell
Biotech and Pharma Reporter, CNBC
Speakers
Michelle McMurry-Heath
President and CEO, Biotechnology Innovation Organization
Mark Suzman
CEO, Bill & Melinda Gates Foundation
Janet Woodcock
Senior Advisor, Food and Drug Administration